Statistics for Remarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma With FGFR Fusion
Total visits
| views | |
|---|---|
| Remarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma With FGFR Fusion | 92 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| UrrutiaArgueta2020Remarkable-AAM.pdf | 155 |
Top country views
| views | |
|---|---|
| United States | 69 |
| Canada | 2 |
| China | 2 |
| Germany | 2 |
| United Kingdom | 2 |
| Japan | 2 |
| Spain | 1 |
| India | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 37 |
| Fairfield | 9 |
| Houston | 4 |
| Washington | 3 |
| Aberdeen | 2 |
| Monsey | 2 |
| Raritan | 2 |
| Toronto | 2 |
| Ann Arbor | 1 |
| Beijing | 1 |
| Cambridge | 1 |
| Duncan | 1 |
| Gunzenhausen | 1 |
| Kiez | 1 |
| Mumbai | 1 |
| San Francisco | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Sevilla | 1 |
| Shenzhen | 1 |
| Stockholm | 1 |
| Westbury | 1 |